ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
64 042,00
0,99%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Pharma Equity Group A/s (0REU)

  7. Pharma Equity Group A/s (0REU) Actualités

0REU Pharma Equity Group A/s

0,40
0,00 (0,00%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pharma Equity Group A/s 0REU London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,40 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,40 0,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/4/202411:45UKREGMajor shareholder announcement - Pharma Equity Group A/S
16/4/202417:29UKREGPassing of the General Meeting of Pharma Equity Group A/S
10/4/202414:21UKREGThe Board of Director's decision to issue convertible loans
05/4/202411:22UKREGPharma Equity Group’s subsidiary, Reponex Pharmaceuticals..
25/3/202413:06UKREGNotice convening the annual general meeting in Pharma Equity..
22/3/202409:00UKREGPharma Equity Group A/S (PEG) enters into an agreement with..
21/3/202416:32UKREGCompletion of subscription of convertible loans
20/3/202408:58UKREGPharma Equity Group A/S - Annual Report 2023
05/3/202410:11UKREGPharma Equity Group's subsidiary (Reponex Pharmaceuticals..
07/2/202413:38UKREGCompletion of subscription of convertible loans
07/2/202409:46UKREGThe Board of Director's decision to issue convertible loans
25/1/202410:08UKREGCompletion of subscription of convertible loans
22/1/202416:15GLOBENotification from the European Patent Office (EPO) regarding..
22/1/202415:54GLOBEThe Board of Director's decision to issue convertible loans
28/11/202318:30GLOBEStatus of the Company's receivable from Portinho S.A.
28/11/202314:56GLOBE2024 Financial Calendar
16/11/202312:17GLOBEPharma Equity Group’s subsidiary (Reponex Pharmaceuticals..
16/11/202308:26GLOBEConsolidated interim report 1 January – 30 September 2023
02/11/202315:14GLOBEResolutions of the Extraordinary General Meeting of Pharma..
31/10/202313:18GLOBEPharma Equity Group's subsidiary (Reponex Pharmaceuticals..
31/10/202311:56GLOBEPharma Equity Group’s subsidiary company (Reponex..
11/10/202312:27GLOBENotice convening the extraordinary general meeting of Pharma..
25/9/202320:49GLOBEStatus of the Company's receivables from Portinho S.A.
16/8/202308:19GLOBEConsolidated interim report 1 January – 30 June 2023
15/8/202313:54GLOBEPharma Equity Group’s subsidiary company (Reponex..
30/6/202317:56GLOBEStatus of the company's receivables from Portinho S.A. with..
15/6/202312:00GLOBEChanges to the Board of Directors in Pharma Equity Group 
14/6/202308:30GLOBENew CMO in Pharma Equity Groups subsidiary Reponex..
08/6/202317:00GLOBEEncouraging preliminary data from the first part of a..
02/6/202311:52GLOBESettlement - Purchase of shares
25/5/202310:31GLOBEManagers’ transactions
10/5/202306:49GLOBEConsolidated interim report 1 January – 31 March 2023

Dernières Valeurs Consultées

LSE
0REU
Pharma Equity Group A/s
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés